COVID-19 UPDATE: We are open! Our team is working and offering consultations via phone, e-mail, and video conferencing.


Federal Judge Sets First Hearing For Consolidated Actos Lawsuits

A federal judge in Louisiana has scheduled the first hearing for a collection of Actos lawsuits filed on behalf of patients who developed bladder cancer after taking the diabetes drug. In December, the U.S. Judicial Panel on Multidistrict Litigation assigned U.S. District Judge Rebecca Doherty to preside over dozens of Actos side effect lawsuits filed against drug maker Takeda Pharmaceuticals America Inc. and its related companies. In an order issued just last week, Judge Doherty announced that she plans to appoint lead attorneys for the consolidated cases after the status conference in Lafayette, Louisiana, which is scheduled for March 22. If you took the diabetes drug Actos and have since suffered from bladder cancercontact an experienced Actos attorney to discuss your legal options.


Actos (pioglitazone) garnered FDA approval in 1999 as a treatment for Type 2 diabetes in adults. Takeda co-promoted the medication in the United States with Eli Lilly & Co., until Takeda took over responsibility for the drug’s marketing in 2006, when the agreement between the two companies ended. Takeda’s Japanese parent company, Takeda Pharmaceuticals Co. Ltd., terminated Actos sales in France and Germany last year amid concerns about possible bladder cancer side effects. The FDA issued an Actos side effect warning concerning bladder cancer in 2010, but allowed sales to continue.


The first Actos lawsuit was filed against Takeda and Eli Lilly in July 2011, report the companies’ lawyers, and Judge Doherty is now handling about 150 of these lawsuits. Thousands of other Actos lawsuits are expected to be heard in Illinois and California state courts. The Actos lawsuits allege that studies have found a connection between the use of Actos for more than one year and an increased risk of bladder cancer. The suits also accuse Takeda of withholding information about Actos bladder cancer risks, and failing to adequately warn consumers and healthcare professionals about this risk. If you or a loved one has suffered from bladder cancer, which you believe to be associated with the diabetes drug Actos, contact a qualified drug injury attorney, as you may be entitled to financial compensation for your injuries and medical expenses.